About IMD Natural Solutions
IMD Natural Solutions is a Healthcare company based in Dortmund (Germany) founded in 2012, and was acquired by LANXESS in April 2018. Chemical company with a focus on fine and specials chemicals derived from natural sources. IMD Natural Solutions has raised $4.47 million across 1 funding round from investors including LANXESS and Zhejiang Hisun Pharmaceuticals. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
IMD Natural Solutions is a chemicals company specializing in chemicals derived from natural sources. The company has multiple natural product libraries derived from a collection of over 40,000 fungal and bacterial species, and approximately 6,000 plant species, algae, and other biological source material. The company provides its compound library in HTS screenable format that can be accessed by companies in various industries for discovery. IMD also has an informatics platform that integrates public and proprietary data into a Natural Product Profile system that can provide biological activity profiles and chemical information on candidates. The company leverages its compound libraries, informatics platform, and its own expertise in the chemistry, biology, pharmacology and toxicology of natural products to deliver commoditized services to clients that include screening, lead discovery, process development and optimization, fermentation, and analytical services.
- Headquarters Dortmund, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website imd-natural-solutions.com
- Acquired by LANXESS (Apr 2018)
Funding Insights of IMD Natural Solutions
IMD Natural Solutions has successfully raised a total of $4.47M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.47 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.47M
- Total Rounds 1
- Last Round Series A — $4.47M
- First Round $4.47M
(Aug 2015)
- Investors Count 1
All 1 funding rounds of IMD Natural Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2015 | $4.47M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in IMD Natural Solutions
IMD Natural Solutions has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include LANXESS and Zhejiang Hisun Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical APIs, formulations, and animal health products are manufactured. | 1956 | hisunpharm.com | Taizhou, China | |
Chemical company | 1981 | lanxess.com | Cologne, Germany |
Investor details for IMD Natural Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IMD Natural Solutions
3 dated milestones of IMD Natural Solutions across 6 years, from founding to its latest funding, stage changes and deals.
- Founded IMD Natural Solutions is founded.
- Funding First funding round of $4.5M.
- Exit Acquired by LANXESS.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IMD Natural Solutions
IMD Natural Solutions was founded in 2012 and raised its 1st funding round 3 years after it was founded.
IMD Natural Solutions is headquartered in Dortmund, Germany. It is registered at Dortmund, North Rhine-westphalia, Germany.
IMD Natural Solutions is a funded company, having raised a total of $4.47M across 1 funding round to date. The company's 1st funding round was a Series A of $4.47M, raised on Aug 2015.
IMD Natural Solutions is a chemicals company specializing in chemicals derived from natural sources. The company has multiple natural product libraries derived from a collection of over 40,000 fungal and bacterial species, and approximately 6,000 plant species, algae, and other biological source material. The company provides its compound library in HTS screenable format that can be accessed by companies in various industries for discovery. IMD also has an informatics platform that integrates public and proprietary data into a Natural Product Profile system that can provide biological activity profiles and chemical information on candidates. The company leverages its compound libraries, informatics platform, and its own expertise in the chemistry, biology, pharmacology and toxicology of natural products to deliver commoditized services to clients that include screening, lead discovery, process development and optimization, fermentation, and analytical services.
IMD Natural Solutions has 2 investors. Key investors include LANXESS, and Zhejiang Hisun Pharmaceuticals.
Yes. IMD Natural Solutions was acquired by LANXESS in April 2018.